Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CDT

Conduit Pharmaceuticals Inc

Dec 11 • 01:07PM ET

0.0893

Dollar change -0.0047
Percentage change -5.01	%

Healthcare • Biotechnology • USA • NASD

Peers: JNJ ABBV MRK AMGN NVS PFE LLY GILD AZN BMY

| Held by: VXF IWC IWN VTWO IWO VTWG RSSL VTWV UWM URTY

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.21	Insider Own	47.38%	Shs Outstand	96.00M	Perf Week	-7.38%
Market Cap	10.70M	Forward P/E	-	EPS next Y	-	Insider Trans	-28.17%	Shs Float	61.46M	Perf Month	-10.71%
Income	-13.64M	PEG	-	EPS next Q	-	Inst Own	3.47%	Short Float	2.53%	Perf Quarter	-35.35%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-27.88%	Short Ratio	0.07	Perf Half Y	-95.85%
Book/sh	-0.09	P/B	-	EPS next Y	-	ROA	-181.68%	Short Interest	1.55M	Perf Year	-98.49%
Cash/sh	0.00	P/C	71.37	EPS next 5Y	-	ROE	-89.65%	52W Range	0.08 - 7.83	Perf YTD	-98.04%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-98.86%	Beta	2.20
Dividend TTM	-	Quick Ratio	0.12	Sales past 5Y	0.00%	Gross Margin	-	52W Low	13.16%	ATR (14)	0.01
Dividend Ex-Date	-	Current Ratio	0.12	EPS Y/Y TTM	-524.01%	Oper. Margin	-	RSI (14)	42.93	Volatility	7.57% 13.45%
Employees	7	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-2290.32%	Payout	-	Rel Volume	0.18	Prev Close	0.09
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	22.53M	Price	0.09
SMA20	-6.66%	SMA50	-12.07%	SMA200	-93.19%	Trades		Volume	2,373,521	Change	-5.01%

Nov-21-24 07:30AM	Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders (GlobeNewswire) +16.90%
Nov-19-24 04:30PM	Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors (GlobeNewswire)
Nov-05-24 07:40AM	Conduit Pharmaceuticals announces new addition to autoimmune pipeline (TipRanks) +6.80%
Nov-04-24 07:30AM	Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline (GlobeNewswire) +11.80%
Nov-01-24 04:45PM	Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes (GlobeNewswire)
08:00AM	Loading…
Aug-28-24 08:00AM	Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -5.54%
Aug-12-24 07:00AM	Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders (GlobeNewswire) -10.53%
Aug-08-24 06:30AM	Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments (GlobeNewswire)
Jul-16-24 02:52PM	Conduit Pharmaceuticals Granted Patent Approval For Autoimmune Diseases Treatment (Exec Edge)
08:12AM	Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today? (InvestorPlace)
07:43AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
07:30AM	Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases (GlobeNewswire)
Jun-13-24 08:00AM	Conduit Pharmaceuticals to Join Russell 3000 Index (GlobeNewswire) -6.05%
May-29-24 04:21PM	A Presidio Property Trust Major Investment To Be Part of Russell 2000 (GlobeNewswire)
May-15-24 09:53AM	CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q1 2024 (InvestorPlace)
10:57AM	Loading…
Mar-19-24 10:57AM	Conduit Pharmaceuticals Adds Key Leadership Positions (Exec Edge)
07:00AM	Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer (GlobeNewswire)
Mar-11-24 02:26PM	Conduit Pharmaceuticals Opens New Laboratory in UK (Exec Edge) +32.37%
07:00AM	Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub (GlobeNewswire)
Jan-31-24 08:30AM	Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire) -7.42%
Nov-02-23 08:30AM	Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference (GlobeNewswire)
Oct-30-23 08:39AM	Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today? (InvestorPlace) +49.52%
Oct-11-23 08:30AM	Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656 (GlobeNewswire) -12.00%
Oct-06-23 09:29AM	Conduit Pharma CEO Tapolczay on Biopharma Differentiation, Pipeline (Exec Edge) -13.83%
08:30AM	Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW) (GlobeNewswire)
Sep-22-23 09:01AM	Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination (GlobeNewswire)
Sep-20-23 05:40PM	Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited (ACCESSWIRE) -8.94% +32.32%
Sep-13-23 08:30AM	Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives (GlobeNewswire)
Sep-07-23 04:30PM	Murphy Canyon Acquisition Corp. Announces Postponement of Its Special Meeting of Stockholders for Approving Its Initial Business Combination With Conduit (ACCESSWIRE)
Aug-31-23 04:05PM	Murphy Canyon Acquisition Corp. Announces Postponement of its Special Meeting of Stockholders for Approving its Initial Business Combination with Conduit (ACCESSWIRE)
08:30AM	Loading…
Aug-16-23 08:30AM	SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Murphy Canyon Acquisition Corp. with Conduit Pharmaceuticals Limited (ACCESSWIRE)

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nirland Ltd	10% Owner	Oct 03 '24	Sale	0.10	1,500,000	156,450	8,400,000	Oct 07 07:38 PM
Nirland Ltd	10% Owner	Oct 04 '24	Sale	0.10	1,368,991	140,458	7,031,009	Oct 07 07:38 PM
Nirland Ltd	10% Owner	Oct 07 '24	Sale	0.10	939,009	96,530	6,092,000	Oct 07 07:38 PM
Nirland Ltd	10% Owner	Oct 01 '24	Sale	0.11	1,250,000	141,375	10,233,177	Oct 02 05:02 PM
Nirland Ltd	10% Owner	Sep 30 '24	Sale	0.12	1,016,823	122,019	11,483,177	Oct 02 05:02 PM
Nirland Ltd	10% Owner	Oct 02 '24	Sale	0.10	333,177	34,251	9,900,000	Oct 02 05:02 PM
Regan Andrew	Director	Jul 16 '24	Sale	0.32	10,244,392	3,246,448	1,691,727	Sep 19 05:01 PM
Regan Andrew	Director	Jul 17 '24	Sale	0.26	1,514,100	391,092	177,627	Sep 19 05:01 PM
Regan Andrew	Director	Jul 12 '24	Sale	0.25	1,389,820	343,425	12,941,319	Sep 19 05:01 PM
Regan Andrew	Director	Jul 11 '24	Sale	0.29	882,952	260,253	14,331,139	Sep 19 05:01 PM
Regan Andrew	Director	Jul 15 '24	Sale	0.25	1,005,200	248,385	11,936,119	Sep 19 05:01 PM
Regan Andrew	Director	Jul 10 '24	Sale	0.33	150,000	50,070	15,214,091	Sep 19 05:01 PM
Regan Andrew	Director	Jul 09 '24	Sale	0.44	77,681	33,853	15,364,091	Sep 19 05:01 PM
Regan Andrew	Director	Jul 08 '24	Sale	0.51	35,923	18,321	15,441,772	Sep 19 05:01 PM
Regan Andrew	Director	Jul 03 '24	Sale	0.64	1,000	640	15,477,695	Sep 19 05:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDT

Conduit Pharmaceuticals Inc

Upgrade your FINVIZ experience